Search for Clinical Trial Results
Hyperparathyroidism, Secondary - 25 Studies Found
Status | Study |
Completed |
Study Name: Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism Condition: Secondary Hyperparathyroidism Date: 2010-12-03 Interventions:
|
Completed |
Study Name: Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT) Condition: Secondary Hyperparathyroidism Date: 2009-01-22 Interventions:
|
Completed |
Study Name: Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients Condition: Secondary Hyperparathyroidism Date: 2015-01-11 Interventions: Drug: Combination Cinacalcet with Vitamin D analogue Depending on the iPTH level and the serum calcium l |
Completed |
Study Name: LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients Condition: Secondary Hyperparathyroidism Date: 2010-07-02 Interventions: Drug: LEO 27847 First in patient |
Completed |
Study Name: Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation Condition: Secondary Hyperparathyroidism Date: 2010-04-19 Interventions:
|
Completed |
Study Name: A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism Condition: Secondary Hyperparathyroidism Date: 2012-07-25 Interventions: Drug: DP001 DP001 softgel capsules; 55 ng to 550 ng per dose, administered 3 times weekly for 4 weeks |
Recruiting |
Study Name: Optimal Anemia Treatment in End Stage Renal Disease (ERSD) Condition: Hyperparathyroidism, Secondary Date: 2014-06-27 Interventions:
|
Terminated |
Study Name: Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism Condition: Secondary Hyperparathyroidism Date: 2012-04-05 Interventions: Drug: Etelcalcetide Administered as an intravenous bolus three times a week at the end of each hemodialy |
Completed |
Study Name: ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism Condition: Secondary Hyperparathyroidism Date: 2005-08-24 Interventions:
|
Completed |
Study Name: Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. Condition: Secondary Hyperparathyroidism Due to Renal Causes Date: 2013-08-28 Interventions:
|